(including RHDV2) known to be present in Australia and tested in a series of available immunological 23 assays originally developed for the prototype RHDV, to assess patterns of cross reactivity and the 24 usefulness of these assays to detect lagovirus antibodies, either in a generic or specific manner. 25 Enzyme Linked Immuno Sorbent Assays (ELISAs) developed to detect antibody isotypes IgM, IgA and 26 IgG were sufficiently cross reactive to detect antibodies raised against all four virulent lagoviruses. 27
For the more specific detection of antibodies to the antigenically more different RHDV2, a 28 competition ELISA was adapted using RHDV2 specific monoclonal antibodies in combination with 29 Australian viral antigen. Archival serum banks from a long term rabbit monitoring site where rabbits 30 were sampled quarterly over a period of six years were re-screened using this assay, and revealed 31 serological evidence for the arrival of RHDV2 in this population at least six months prior to its initial 32 detection in Australia in a deceased rabbit in May 2015. The serological methods and reference 33 reagents described here will provide valuable tools to study presence, prevalence and impact of 34 RHDV2 on Australian rabbit populations; however the discrimination of different antigenic variants 35 of RHDVs as well as mixed infections at the serological level remains challenging. 36
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Introduction: 41
Rabbit Haemorrhagic Disease Virus (RHDV, sometimes also referred to as RHDV1 or GI.1c, according 42 to a new proposed nomenclature (Le Pendu et al., 2017) ), belongs to the genus lagovirus within the 43 family caliciviridae. RHDV was released in Australia as a biological control agent for introduced wild 44 rabbits, a devastating agricultural and environmental pest species in this country (Cooke and Fenner, 45 2002) . While initially very effective in reducing rabbit populations across large parts of the continent (Saunders et al., 2002 , Mutze et al., 1998 , RHDV was not effective in the more temperate areas of South Eastern Australia. This lack of effectiveness was likely due to the presence of endemic, non-48 pathogenic caliciviruses (Rabbit calicivirus Australia 1, also termed RCV-A1, or GI.4) that can provide 49 transient and partial immunological cross protection to RHDV , Liu et al., 2014 , 50 thereby reducing both case fatality and infection rates (Cooke et al., 2018) . In addition to the 51 impeding effects of RCV-A1, rabbit populations have been recovering in recent years (Mutze et al., 52 2014) , and developing genetic resistance to RHDV has been reported in some Australian rabbit 53 populations (Elsworth et al., 2012 , Nystroem et al., 2011 . In an attempt to 'boost' rabbit biocontrol 54 in Australia and to maintain the substantial economic and environmental gains made by the long 55 term suppression of rabbit populations by RHDV (Pedler et al., 2016 , Cooke, 2013 , an additional 56 strain of RHDV was released nationwide in Australia in March 2017 (Hall et al., 2018, Strive and Cox, 57 2019 ). This strain termed RHDVa-K5 is a naturally occurring antigenic variant of RHDV from Korea 58 (Oem et al., 2009 ) which was shown experimentally to be more effective in infecting rabbits from a 59 genetically resistant rabbit population (Elsworth et al., 2012) and in overcoming partial protection 60 conveyed by the benign RCV-A1 (Cox et al., 2013) . These antigenic variants of RHDV, referred to as 61 RHDVa (GI.1a, or RHDV1a), were first reported in the late 1990s (Capucci et al., 1998) , and although 62 they exhibit antigenic differences they are considered to be of the same serotype (Lavazza and 63 . 64
Prior to the release of RHDVa-K5, the incursions of two additional RHDV variants were reported in 65
Australia. The first incursion was another variant RHDVa (GI.1a) strain in the greater Sydney area 66 that most closely resembled a Chinese isolate (Wang et al., 2012 ) that appeared in early 2014. This 67 virus, termed RHDVa-Aus, caused a number of recorded outbreaks mostly in domestic rabbit farms, 68 however, its distribution appeared geographically limited to the east and north east of New South 69
Wales (Mahar et al., 2018b) . In May 2015, the incursion of a second exotic virus, the recently 70 emerged RHDV2 (GI.2) was reported in Australia (Hall et al., 2015 Puggioni et al., 2013 , Velarde et al., 2017 . Since its arrival in Australia, RHDV2 has become 77 the dominant strain circulating in the field, seemingly replacing older RHDV1 strains and accounting 78 for the majority of reported cases in wild and domestic rabbits (Mahar et al., 2018a) . 79
With the increasing diversity of co-circulating RHDVs both in Australia and Europe it was essential to 80 update the diagnostic tools available, to allow for specific identification of strains and to measure 81 the impact they were having on wild rabbit (and hare) populations. Due to the genetic variability, the 82 development of specific molecular diagnostics was comparably straightforward, and accordingly 83 several tailored approaches have been described in both Europe and Australia ( In Australia, the development of specific serological tools to discriminate between different 92 lagoviruses was of particular importance. Here, RHDV2 was actively circulating at the time the new 93 strain RHDVa-K5 was released nationwide (Strive and Cox, 2019) and specific serological tools were 94 needed to investigate the respective impacts and potential interactions the two strains had on wild 95 Australian rabbits at a population level. Furthermore, in the years leading up to the national release 96 of RHDVa-K5, extensive serological monitoring of several Australian rabbit populations was carried 97 out. Screening these sample banks with a serological assay specific to RHDV2 might allow a more 98 accurate determination of the exact time point this virus entered into Australia and started to 99 circulate in wild rabbit populations before it was detected in May 2015 (Hall et al., 2015) . 100
This study describes the production of reference sera raised against all virulent RHDV strains known 101 to be circulating in Australia for the purpose of assessing the cross-reactivity patterns in a panel of 102 existing serological assays used to infer disease dynamics of RHDV in rabbit populations. It further 103 describes the adaptation of a European RHDV2 cELISA to the Australian strain of RHDV2, and the 104 modification of IgM and IgA isotype ELISAs for the improved detection of RHDV2 antibodies. The 105 RHDV2 cELISA was then applied to retrospectively analyse a long term field monitoring site to 106 estimate the time of arrival on RHDV2 at this site. 107 108
Material and methods: 109
Ethics approval: 110 All work involving animals was approved by the CSIRO Ecosystem Sciences Animal Ethics Committee 111 (ESAEC #10-13, #11-01, #13-01, #13-10, #DOMRAB) and the Orange Animal Ethics Committee 112 (ORA11/14/001, ORA14/17/001) and carried out in accordance with the Australian code for the care 113 and use of animals for scientific purposes. 114
Production of antigen, virus inoculum and experimental vaccine 115
Two five week old New Zealand white rabbits were infected with 0.5 ml of a 2% clarified liver 116 homogenate of the first RHDV2 field isolate found in Australia (BlMt-1, Gen Bank# KT280060) (Hall et 117 al., 2015) . Rabbits were monitored twice daily for signs of terminal rabbit haemorrhagic disease 118 (RHD), which was defined as 10% weight loss within a 24 hour period, no resistance to handling or 119 lateral recumbency, or hypothermia following a fever episode, often in combination with lethargy. 120
Both rabbits experienced a peracute form of RHD, one was found displaying signs of terminal RHD at 121 66 hours post infection (h.p.i.) and was euthanized, the second was found dead 90 h.p.i. with no 122 prior signs of terminal RHD detected. 123
The liver of one of the RHDV2 infected rabbits was used for the production of an experimental 124 vaccine, according to methods published previously . Briefly, a 20% w/v 125 liver homogenate (containing approximately 3 x 10 8 capsid gene copies/ml) was prepared in sterile 126 PBS and clarified by centrifugation for 20 min at 2,000 g. Chloroform was added to the supernatant 127 to a final concentration of 2% (v/v) and incubated at 4°C overnight, followed by a second clarification 128 at 10,000g and 4°C. Part of the clarified supernatant was removed, mixed 1:1 with glycerol and 129 stored at -80°C as RHDV2 inoculum for subsequent infections (0.5 ml/rabbit). Formalin was added to 130 the remaining supernatant to a final concentration of 0.8% v/v and incubated at room temperature 131 overnight. A second inactivation step was performed by adding formalin to a total concentration of 132
1% v/v with overnight incubation at 4°C. This preparation was stored at 4°C until used. Immediately 133 prior to use, the vaccine was brought to room temperature, mixed 1:1 with Addavax (Invivogen, San 134 Diego, USA), and between 0.6 and 1.2 ml were injected subcutaneously in the scruff of the neck. 135
For the production of RHDV2 ELISA antigen, a 10% w/v homogenate of the liver of the second rabbit 136 was clarified using two centrifugation steps (20 min at 3000g, followed by 30 min at 6000g, at 4°C), 137 and then passed through a 0.8 µm filter. The resulting homogenate was mixed 1:1 with glycerol and 138 stored at -80°C. 139
A commercially produced preparation of RHDVa-K5 was used as inoculum to produce hyperimmune 140 sera, diluted to 10,000 RID 50 /ml (Elizabeth Macarthur Agricultural Institute, Menangle, Australia). 141
RHDVa-Aus inoculum was prepared from a 2% of clarified liver homogenate of RHDVa-Aus (Ber-3, 142
GenBank # KY628310) (Mahar et al., 2018b) . The infectious dose of the RHDVa-Aus and the RHDV2 143 inoculum was not titrated. 144
Production of reference sera
For the production of RHDVa hyperimmune sera, five-week old rabbits were infected with RHDVa-146 Aus (n=4) and RHDVa-K5 (n=5). Due to the age related innate resistance to lethal RHDV infection 147 (Matthaei et al., 2014 , Neave et al., 2018 it was expected that rabbits of this age group would not 148 succumb to fatal RHDV infection, but survive and mount a strong antibody response. Rabbits were 149 orally infected with 0.5 ml of virus inoculum using a 1 ml syringe. Rabbits were monitored twice daily 150 for the first four days and then daily afterwards. A small (0.1-0.2 ml) blood sample was collected 151 from the marginal ear vein at day 0, 7 and 14. Two rabbits in each group were sacrificed and bled at 152 14 dpi the remaining rabbits at 20 dpi (RHDVa-K5) and 22 dpi (RHDVa-Aus) ( Table 1) . 153
Archival serum samples from five rabbits collected at various time points were used as RHDV 154 hyperimmune reference sera. In this previous study (T. Strive, unpublished), three 5 week old New 155
Zealand white rabbits were infected orally with 500 ID 50 of a commercial RHDV preparation (RHDV 156 v351, Elizabeth Macarthur Agricultural Institute, Menangle, Australia), blood samples were collected 157 at 7 dpi and a final bleed was carried out at 14 dpi. Hyperimmune RHDV sera from an additional four 158 rabbits harvested at various time points were available from a previous study (Matthaei et al., 2014) . 159
Seven RCV-A1 polyclonal sera were also included (Liu et al., 2012b), as well as an additional seven 160 negative control sera. 161
For the production of RHDV2 polyclonal sera, rabbits needed to be partially vaccinated prior to the 162 challenge, as young rabbits are not innately resistant to lethal RHDV2 infection (Neimanis et al., 163 2018a ). Three five-week old rabbits and two adult rabbits of approximately three years of age were 164 injected with the experimental vaccine preparation as described above. One adult animal was 165 challenged 10 days after vaccination (dpv) the remaining four rabbits in this group were challenged 166 six dpv. Monitoring and blood sampling of these animals was carried out as for the RHDVa infected 167 rabbits (Table 1) . 168 IgG isotype ELISAs were observed in sera raised against RHDVa-Aus and RHDVa-K5 compared to the 220 RHDV-Czech polyclonal sera (Table 1) . Sera raised against RHDV2 also showed varying levels of cross-221 reactivity in this assay, but with different patterns. Cross-reactivity was highest in the IgG ELISA, with 222 detectable titres in all animals at 8 dpi, and in one case day 6 post vaccination and prior to RHDV2 223 challenge. IgM antibodies were detected in all RHDV2 polyclonal reference sera although titres were 224 lower compared to those of the RHDVa-K5, RHDV-Aus and RHDV-Czech reference sera collected at 225 similar time points post infection. IgA antibodies are indicative of active replication of RHDV 226 following a natural infection and are not seen in rabbits treated with inactivated vaccines (Lavazza 227 and Capucci, 2016) and accordingly, no IgA responses were observed in this group following 228 vaccination. IgA cross-reactivity in the RHDV2 polyclonal sera was present but with overall lower 229 titres and with a later onset compared to rabbits infected with RHDV and RHDVa strains, indicating 230 an active but possibly attenuated infection with RHDV2 in these previously vaccinated animals (Table  231 1). Overall, the IgM and IgA isotype ELISAs originally developed for RHDV appear suitable to detect 232 disease activity of all circulating virulent strains in wild rabbit populations, although the sensitivity of 233 detection may be slightly reduced. 234
Increased sensitivity and specificity in the RHDV2 adapted IgA and IgM ELISAs 235
When the isotype ELISAs for IgA and IgM were adapted to RHDV2 specific reagents, the titres of the 236 RHDV2 reference sera were at least four fold greater when compared to the respective original 237 RHDV isotype assays, and where sufficient amounts of serum were available for testing, both IgM 238 and IgA antibodies were detected earlier (Table 1) . RHDV-Czech, RHDVa-K5, and RHDVa-Aus 239 reference sera also cross-reacted in the RHDV2 IgM and IgA ELISA, but had lower titres compared to 240 the RHDV2 reference sera (Table 1 ). Due to the high level of cross reactivity of RHDV2 polyclonal 241 sera in the in the IgG assay, the IgG isotype ELISA was not adapted. 242
Cross-reactivity of reference sera in specific competition or blocking ELISAs for RCV-A1, RHDV and 243
RHDV2 244
The RHDV2 cELISA developed here from Australian and European reagents proved to be highly 245 sensitive and specific. Low levels of reactivity were detected as early as 6 dpv with titres increasing 246 until the end of the trial (Table 1) . Sera raised against RHDV-Czech, RHDVa-Aus and RHDVa-K5 only 247 showed low levels of cross-reactivity in this assay, only in one case exceeding titres of 1:40 (1:160, 248 K#315, 22 dpi, Table 1 ). None of the seven archival RCV-A1 control sera reacted in the RHDV2 cELISA. 249
In contrast, the RHDV cELISA showed low to moderate levels of cross-reactivity with RHDV2 250 polyclonal sera, and very high levels of cross-reactivity with the sera raised against the two RHDVa 251 strains (Table 1) . Only one of the RHDV-Czech reference sera tested here showed a very low level of 252 cross-reactivity with the RCV-A1 bELISA (1:10, K#177, 14 dpi, Table 1 ). Only sera from the terminal 253 bleeds were tested in the RHDV cELISA and RCV-A1 bELISA as there was not sufficient serum left 254 from the previous sampling points. 255
The ratio of the two specific cELISAs for RHDV and RHDV2 can be used to infer the presence of RHDV2 256 specific antibodies 257
We explored if the ratios between the RHDV and RHDV2 cELISAs could be used to infer the presence 258 of RHDV2 antibodies in the populations, similar to an approach used previously to discriminate 259 between RHDV2 and European Brown Hare Syndrome Virus (EBHSV) antibodies in wild hare 260 populations in Europe (Velarde et al., 2017) . While there was some level of cross-reactivity between 261 the respective cELISAs in the reference sera produced for this study, the titres were always higher 262 for the respective specific viral antigen. To investigate this further, negative results were set to a 263 titre of 1:5 for the purpose of forming ratios between reciprocal titres, and only samples were included in the analysis that had returned a positive reaction in either of the two assays, as 265 described previously (Velarde et al., 2017) . Due to the high likelihood of cross reactivity at very low 266 dilutions, only test results > 1:40 were considered for this analysis. The RHDV2 cELISA/RHDV cELISA 267 titre ratios were >1 in all reference sera raised against RHDV2, with ratios ranging from 1 to 100. In 268 all reference sera raised against RHDV or RHDVa the ratios were <1, ranging from 0.008 to 0.125 for 269 sera raised against RHDVa-K5 and RHDVa-Aus, and from 0.0002 to 0.0156 for sera raised against 270
RHDV-Czech. 271
We then applied this method to retrospectively test archival serum samples collected at the Oakey 272
Creek long term study site where these were available. Here, approximately 20 rabbits had been 273 sampled quarterly since January 2012 and analysed with the serological assays originally developed 274 for RHDV (Cooke et al., 2000) . RHDV IgM and IgA assays were only carried out at a 1:40 dilution to 275 detect presence or absence of recent disease activity but were not titrated. These samples were re-276 tested in the RHDV2 cELISA described here to determine the time of RHDV2 arrival at this site. 277
Initially we analysed a very early sample of n=20 rabbits from autumn 2012 as a negative baseline, as 278 it was considered very unlikely that RHDV2 would have been present in Australia over three years 279 prior to its detection. We then continued the analysis starting with the most recent samples, 280 working backwards until four consecutive samples showed no serological evidence of RHDV2. 281
Unexpectedly, serological analysis revealed clear evidence for presence of RHDV2 antibodies in this 282 population with several samples resulting in an RHDV2cELISA/RHDVcELISA ratio of >1 as early as 283 January 2015 (Figure 1 ). This indicates that RHDV2 must have arrived at this site sometime between 284 the sampling periods October 2014 and January 2015, which pre-dates the first case report of 285 RHDV2 in a deceased rabbit by at least six months (Hall et al., 2015) . While fluctuating, overall 286 seroprevalence to RHDV2 increased in later sampling periods coinciding with an overall decrease of 287 animals classified as positive to RHDV. 288 Some level of cross reactivity was observed in the RHDV2 cELISA prior to RHDV2 arrival. Four out of 289 96 samples analysed that were collected prior to January 2015 showed low level cross reactivity in 290 the RHDV2 cELISA with titres between 1:40 and 1:80. However in all these cases the individual 291 rabbits had higher titres in the RHDV cELISA resulting in a ratio of <1 in all cases. 292
IgM antibodies indicative of recent lagovirus outbreaks were frequently detected in this population 293 prior to the arrival of RHDV2, namely in winter and spring 2012, summer 2014, and winter and 294 spring 2014. No evidence for recent virus activity was detected in the following five sampling 295 periods, but then again in autumn and spring 2016, and again in autumn 2017 (Figure 1) . In order to 296 ascertain which virus was likely causing these outbreaks, we investigated the antibody profiles in the 297 recent cohorts of rabbits ( Figure 2 ). Although some rabbit breeding in this part of Australia is 298 possible year round, the main breeding events occur in winter/spring. Accordingly, members of each 299 new cohort of rabbits starts to appear in the summer shot sample, and subsequent sampling periods 300
throughout the year reflect the increase in age of this cohort ( Figure 2) . As expected, all animals 301 scored as positive to RHDV with a cELISA ratio <1 prior to January 2015. After the arrival of RHDV2 at 302 this site, in start to appear in the January 2015 sample. However, evidence for RHDV positive animals 303 in less than 12 months of age was found in January 2017 and October 2017. These animals had not 304 yet been born at the time of RHDV2 arrival, indicating that both RHDV and RHDV2 must have been 305 involved in the three periods of virus activity recorded since RHDV2 arrival at this site. The RHDV 306 cELISA titres in these young rabbits were high, ranging from 1:80 to 1:2560 (1:840 avg), indicating a 307 strong immune response from an active RHDV infection rather than the presence of residual 308 maternal antibodies. 309
Discussion: 310
Specific serology of different lagoviruses can be challenging, as high levels of cross-reactivity are 311 often observed even between antigenically very different members of this genus (Capucci et al., 312 1996b , Liu et al., 2012b , Nagesha et al., 2000 . For the more specific detection of different viruses, less sensitive and more specific cELISAs or bELISAs have been described (Capucci et al., 1991 , Collins 314 et al., 1995 , Liu et al., 2012a , however, isotype ELISAs detecting IgG antibodies are so cross-reactive 315 that they have historically been used to infer the presence of previously unknown and often 316 antigenically quite different lagoviruses (Capucci et al., 1996b , Cooke et al., 2000 2000, Robinson et al., 2002) . 318
These difficulties notwithstanding, there is a need for improved serological tools to discriminate 319 between antibodies to the different lagoviruses circulating in Australia, to better understand their 320 role in naturally occurring disease dynamics as well as biological control operations of wild rabbits. 321
For over two decades only RHDV and RCV-A1 were known to be present in Australia, and their 322 disease dynamics have been studied extensively, utilising specific cELISAs or bELISAs for RHDV and 323 RCV-A1 as well as isotype ELISAs for both viruses ( Disease dynamics of RHDV can be inferred by interpreting the reaction profiles in different isotype 328 and cELISAs (Cooke, 2002) . In this approach, IgM is interpreted as an indicator of a recent outbreak 329 and first time exposure of an individual to RHDV, a boost in IgA titres as a measure for re-exposure 330 to RHDV, and the highly sensitive but cross-reactive IgG is used to infer the presence of maternal 331 antibodies in very young rabbits. In our study, the reference sera raised against RHDV-Czech, RHDVa-332 Aus, RHDVa-K5 and RHDV2 all reacted to varying degrees in these assays, indicating that they should 333 be suitable to detect broad patterns of disease activity caused by any of the virulent lagovirus strains 334 in wild rabbit populations in Australia, however they do not allow for the discrimination between the 335 various strains. 336
Adaptation of the IgM and IgA ELISA to RHDV2 by using RHDV2-specific antigen and Mab increased 337 the sensitivity of these assays for RHDV2 IgM and IgA detection substantially. While the use of the 338 original RHDV IgA and IgM assays is sufficient to infer broader disease activity patterns in wild rabbit 339 populations for all lagoviruses including RHDV2 (Figure 1) , switching to these more sensitive assays 340 for future large scale field epidemiology studies should be considered if RHDV2 remains the 341 dominant strain in the Australian landscape (Mahar et al., 2018a) . 342
The RHDV2 cELISA described here proved to be highly specific for the detection of RHDV2 343 antibodies, with low levels of cross-reactivity to the experimentally produced RHDV and RHDVa 344 reference sera as well as the sera from wild rabbits collected before the arrival of RHDV2 in 345
Australia. In contrast, the existing RHDV cELISA (Capucci et al., 1991) showed low to medium levels 346 of cross-reactivity to RHDV2 and high levels of cross-reactivity to both RHDVa-Aus and RHDVa-K5. 347
However, in the RHDV and RHDV2 cELISAs, titres were higher in the sera raised against the 348 respective strain, such that the ratios of the reciprocal titres of the two assays can be used to infer 349 which strain the rabbit was most likely exposed to. It needs to be noted that this method classifies 350 rabbits into positive to either RHDV or RHDV2, and therefore does not allow for the detection of 351 mixed infections and the true prevalence to both RHDV and RHDV2 is likely underestimated. 352
However the method does allow to detect presence of RHDV2 and should allow to discern broader 353 trends within rabbit populations. 354
When applied to a sample collection from a long term field monitoring site, this method showed 355 clear evidence for RHDV2 activity in this population at least six months prior to the first RHDV2 case 356 reported in Australia (Hall et al., 2015) , and confirms inferences made from phylogenetic analyses of 357 viral sequences suggesting that RHDV2 had circulated in Australia several months prior to its first 358 detection in May 2015 (Mahar et al., 2018a) . 359
The inclusion of age data into the analysis allowed the confirmation of RHDV activity in this 360 population after July 2016. In addition, including age data into the analysis may provide a more 361 accurate estimate of disease dynamics than analysing overall seroprevalence data alone. A large 362 proportion of rabbits present in every shot sample were >500 days old, and may therefore confound 363 the analysis of recent virus activity. In addition, if some level of immunological cross protection 364 exists between RHDV and RHDV2 (Calvete et al., 2018) , the removal of susceptible rabbits by an 365 RHDV2 outbreak from the population could result in an apparent increase of RHDV seroprevalence, 366 due to the resulting increased proportion of surviving old RHDV seropositive animals in the sample. 367
Conclusions: 368
The analysis of the reference sera as well as field sera collected pre-and post-RHDV2 arrival in 369
Australia indicates that existing RHDV IgA and IgM isotype ELISAs are suitable to infer disease 370 dynamics of all virulent RHDV strains currently circulating in Australia. The ratio between the RHDV2 371 and RHDV cELISA titres allows for the detection of the presence of RHDV2 specific antibodies with 372 high levels of certainty, even in the presence of RHDV or RHDVa antibodies. In combination, the 373 methods described here should allow for retrospective analysis of archival field sera to study the 374 spread and impact of RHDV2 on Australian rabbit populations as well as allow for a more accurate 375 estimate of the time of RHDV2 arrival at various site in Australia. Including rabbit age data, where 376 available, will improve these analyses. However, due to the high levels of cross-reactivity of RHDV2 377 reference sera in the RHDV cELISA, detecting RHDV or RHDVa antibodies in samples collected post 378 RHDV2 arrival is challenging. In particular, inferring mixed infections of RHDV/RHDVa/RHDV2 or 379 confirming the absence of RHDV antibodies in RHDV2 positive populations is difficult to discern. 380
Similarly, distinguishing between antibodies to RHDV and RHDVa strains is not feasible with the 381 serological tools currently available. Despite these remaining challenges in the differential 382 serodiagnostics of Australian lagoviruses, the additional assays described here represent an 383 important addition to the tool kit that will benefit ongoing continent-wide lagovirus epidemiology 384 studies. 385
Competing interests: The authors declare that they have no competing interests. 386
